Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02466308 · ClinicalTrials.gov registry record · NA

Long Duration Therapeutic Ultrasound for Tendon Healing

A NA study of Tendinopathy and Tendinosis, sponsored by ZetrOZ.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02466308 is a NA study of Tendinopathy and Tendinosis that has completed, run by ZetrOZ. The registered enrollment target is 28 participants, below the 1,064-participant average among 10 other Tendinopathy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02466308, a NA study of Tendinopathy and Tendinosis, has completed, sponsored by ZetrOZ.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

ZetrOZ's Ultrasonic Diathermy device (sam(R) Professional System) is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatment of muscle spasm and joint contracture, and increasing local circulation. This study will look at the use of therapeutic ultrasound to relieve pain and enhance tendon extensibility for individuals with tendinopathy over a 6 week time period.

Interventions

  • DEVICE SAM Ultrasound Diathermy Device

Study Locations (1)

Connecticut

  • ZetrOZ, Inc. - Trumbull

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-02
Est. Completion 2014-09
Phase NA

Sponsor

ZetrOZ

17 total trials

What the Registry Record Tells You About NCT02466308

The ClinicalTrials.gov registry entry for NCT02466308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,064-participant average among 10 other Tendinopathy trials with a reported enrollment target (97% lower). The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tendinopathy appearing as the primary indexed condition, and to 1 intervention - of which SAM Ultrasound Diathermy Device is the first listed.

NCT02466308 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02466308 about?

NCT02466308 is a clinical study titled "Long Duration Therapeutic Ultrasound for Tendon Healing". ZetrOZ's Ultrasonic Diathermy device (sam(R) Professional System) is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatm...

What is the current status of trial NCT02466308?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-02. Estimated completion is 2014-09.

What conditions does trial NCT02466308 study?

This clinical trial studies the following conditions: Tendinopathy, Tendinosis, Tendinitis.

What interventions are being tested in trial NCT02466308?

The interventions under investigation include: SAM Ultrasound Diathermy Device (DEVICE).

Who is sponsoring clinical trial NCT02466308?

This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02466308 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tendinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.